RANZCO Congress highlights new horizons in ophthalmology

The RANZCO Congress never fails to attract a high-powered line-up of invited speakers. Part 2 of Insight’s conference coverage features interesting topics, including ocular CRISPR gene editing, arguments for cataract surgery simulation training and the need for true innovations in ophthalmology.
Read More

Rewriting eye disease: Are we ready for gene therapies?

In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment can restore vision in people once resigned to a lifetime of blindness and is expected to pave the way for many more. MYLES HUME analyses the opportunities and challenges posed by ocular gene therapies.
Read More